Literature DB >> 11428172

Corneal collagens.

L Robert1, J M Legeais, A M Robert, G Renard.   

Abstract

Cornea is a highly differentiated tissue rich in extracellular matrix (ECM) specifically distributed in space in order to insure its dual role--transparency and protection of inner eye-tissues. Corneal ECM is especially rich in collagens. Since the characterisation of a number of distinct collagen types it appeared that most of them are present in the cornea. Their synthesis follows a specific program of sequential expression of the different collagen types to be synthesised during the development and maturation of the cornea. The precise regulation of the diameter and orientation of fibers, and of the interfibrillar spaces is partially at least attributed to interactions between glycosaminoglycans and collagens. The 'program' of vectorial collagen synthesis and GAG-collagen interactions changes also with age and in several pathological conditions as corneal dystrophies and wound healing. The Maillard reaction, especially in diabetes, is one of these important factors involved in age-dependent modifications of corneal structure and function. Far from being inert, corneal collagens were shown to have relatively short half-lives. The biosynthesis of corneal collagens was studied also during wound healing. The refibrillation of wounded corneas does not follow the original 'program' of ECM-synthesis as shown by the comparative study of wound healing using biochemical and morphometric methods. This review recapitulates briefly previous and recent studies on corneal collagens in order to present to clinicians and scientists an overview of the state of the art of this important field at the intersection of eye research and matrix biology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428172     DOI: 10.1016/s0369-8114(01)00144-4

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  14 in total

1.  Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking.

Authors:  Yuntao Zhang; Abigail H Conrad; Gary W Conrad
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

2.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.

Authors:  Yuntao Zhang; Xiuli Mao; Tyler Schwend; Stacy Littlechild; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

3.  Unravelling the stromal-nerve interactions in the human diabetic cornea.

Authors:  Shrestha Priyadarsini; Tyler G Rowsey; Jian-Xing Ma; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2017-08-05       Impact factor: 3.467

4.  Rat corneal endothelial cell migration during wound repair on the basement membrane depends more on the PI-3K pathway than the cdc-42 pathway or actin stress fibers.

Authors:  Sheldon R Gordon; Geoffrey H Gordon; Samantha Dimovski
Journal:  Cell Tissue Res       Date:  2020-06-21       Impact factor: 5.249

5.  A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome.

Authors:  Ching Yuan; Erick D Bothun; David R Hardten; Jakub Tolar; Linda K McLoon
Journal:  Exp Eye Res       Date:  2016-05-26       Impact factor: 3.467

6.  Just What Do We Know About Corneal Collagen Turnover?

Authors:  David C Paik; Stephen L Trokel; Leejee H Suh
Journal:  Cornea       Date:  2018-11       Impact factor: 2.651

7.  Human Keratoconus Cell Contractility is Mediated by Transforming Growth Factor-Beta Isoforms.

Authors:  Desiree ' Lyon; Tina B McKay; Akhee Sarkar-Nag; Shrestha Priyadarsini; Dimitrios Karamichos
Journal:  J Funct Biomater       Date:  2015-06-18

8.  Corneal Collagen Cross-Linking in the Treatment of Progressive Keratoconus: A Randomized Controlled Contralateral Eye Study.

Authors:  Mohammad A Seyedian; Soheil Aliakbari; Mohammad Miraftab; Hassan Hashemi; Soheila Asgari; Mehdi Khabazkhoob
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jul-Sep

9.  Establishment of a 3D In Vitro Model to Accelerate the Development of Human Therapies against Corneal Diabetes.

Authors:  Shrestha Priyadarsini; Akhee Sarker-Nag; Tyler G Rowsey; Jian-Xing Ma; Dimitrios Karamichos
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

10.  Expression Profiles of Neuropeptides, Neurotransmitters, and Their Receptors in Human Keratocytes In Vitro and In Situ.

Authors:  Marta Słoniecka; Sandrine Le Roux; Peter Boman; Berit Byström; Qingjun Zhou; Patrik Danielson
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.